EGF+61 A>G polymorphism does not predict response to first‐generation EGFR tyrosine kinase inhibitors in lung cancer patients

por Leal, Leticia F., Laus, Ana C., Cavagna, Rodrigo, de Paula, Flavia E., de Oliveira, Marco A., Ribeiro, Dayana M., Hassan, Fernanda M., Miziara, José E., da Silva, Eduardo C. Albino, da Silva, Vinicius D., De Marchi, Pedro, Reis, Rui M.
Publicado 2020